A Role for Protein Inhibitor of Activated STAT1 (PIAS1) in Lipogenic Regulation through SUMOylation-independent Suppression of Liver X Receptors

Autor: Liu(杨柳) Yang, Weiping J. Zhang, Yongliang Zhang, Zhenji Gan, Mengle Shao, Ping Huang, Luting Zhou, Jia Li, Yan(陈雁) Chen, hao(应浩) Ying, Meina Cao, Xiaomeng Jiang, Ting Mao, Jing-Ya Li, Yong(刘勇) Liu
Rok vydání: 2012
Předmět:
Male
Transcriptional Activation
Hydrocarbons
Fluorinated

Blotting
Western

SUMO protein
Mice
Obese

Peroxisome proliferator-activated receptor
Biology
Ligands
Biochemistry
Mice
chemistry.chemical_compound
Animals
Humans
Gene Regulation
Protein inhibitor of activated STAT
Obesity
Liver X receptor
Fatty acid homeostasis
Molecular Biology
Cells
Cultured

Fatty acid synthesis
Liver X Receptors
chemistry.chemical_classification
Regulation of gene expression
Sulfonamides
Reverse Transcriptase Polymerase Chain Reaction
Lipogenesis
Fatty Acids
Sumoylation
Cell Biology
Orphan Nuclear Receptors
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
Protein Inhibitors of Activated STAT
Mice
Inbred C57BL

HEK293 Cells
Liver
chemistry
Nuclear receptor
Hepatocytes
Trans-Activators
Protein Binding
Transcription Factors
Zdroj: Journal of Biological Chemistry. 287:37973-37985
ISSN: 0021-9258
DOI: 10.1074/jbc.m112.403139
Popis: Liver X receptors (LXRs) are nuclear receptors that function to modulate lipid metabolism as well as immune and inflammatory responses. Upon activation by their ligands, LXRs up-regulate a spectrum of gene transcription programs involved in cholesterol and fatty acid homeostasis. However, the mechanisms by which LXR-mediated transcriptional activation is regulated remain incompletely understood. Here, we show that PIAS1, a member of the protein inhibitor of the activated STAT family of proteins with small ubiquitin-like modifier (SUMO) E3 ligase activity, acts to suppress LXR ligand-dependent transcriptional activation of the lipogenic program in hepatocytes. We found that liver mRNA expression levels of Pias1 and Pias3 were inversely associated with those of genes involved in lipogenesis in mouse models with diet-induced or genetic obesity. Overexpression of PIAS1 in primary hepatocytes resulted in a reduction of LXR ligand-induced fatty acid synthesis and suppression of the expression of lipogenic genes, including Srebp1c and Fas. Moreover, PIAS1 was able to interact with LXRβ and repress its transcriptional activity upon ligand stimulation, which did not require PIAS1-promoted SUMO modification of LXRβ. In addition, PIAS1 could also interact with PGC-1β and attenuate its association with LXRβ, blunting the ability of PGC-1β to co-activate LXRβ. Importantly, PIAS1 impaired LXRβ binding to its target DNA sequence. Taken together, our results suggest that PIAS1 may serve as a lipogenic regulator by negatively modulating LXRs in a SUMOylation-independent manner.
Databáze: OpenAIRE